Revolutionary ‘anthrobots’ from human cells: A leap in healing and drug delivery

In a groundbreaking study, scientists have developed “anthrobots” from adult human lung cells, capable of autonomous movement and initiating wound healing in human neurons.

BridgeBio Oncology and Helix enter definitive merger agreement

BBOT’s BBO-8520 is currently undergoing the Phase I ONKORAS-101 trial. Credit: CrizzyStudio/Shutterstock. BridgeBio Oncology has entered a definitive merger agreement with Helix Acquisition Corp II,

March 3, 2025

DNA repair gene mutations predict bladder cancer response to neoadjuvant chemotherapy

An analysis of pre-treatment tumor specimens from 105 patients with localized muscle-invasive bladder cancer found that the presence of a mutation in any one of

July 30, 2024

Opinion | Why Don’t Men Have Their Version of ‘The Pill’?

Pauling is a mother, a DEI executive, and a former civil rights litigator. Last fall, my first-year University of Miami daughter came to me with

May 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.